Biology Reference
In-Depth Information
141. Maier B, Schwerdtfeger K, Mautes A, Holanda M, Muller M, Steudel WI, et al.
Differential release of interleukins 6, 8, and 10 in cerebrospinal fluid and plasma after
traumatic brain injury. Shock 2001;15:421-26.
142. Giulian D, Chen J, Ingeman JE, George JK, Noponen M. The role of mononuclear
phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci
1989;9:4416-29.
143. Yan HQ, Banos MA, Herregodts P, Hooghe R, Hooghe-Peters EL. Expression of inter-
leukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after
injury. Eur J Immunol 1992;22:2963-71.
144. Knoblach SM, Faden AI. Interleukin-10 improves outcome and alters proinflam-
matory cytokine expression after experimental traumatic brain injury. Exp Neurol
1998;153:143-51.
145. Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X. Inhibitory effect on cerebral inflam-
matory agents that accompany traumatic brain injury in a rat model: a potential neuro-
protective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Letters
2007;425:177-82.
146. Lieutaud T, Andrews PJD, Rhodes JKJ, Williamson R. Characterization of the pharma-
cokinetics of human recombinant erythropoietin in blood and brain when administered
immediately after lateral fluid percussion brain injury and its pharmacodynamic effects
on IL-1beta and MIP-2 in rats. J Neurotrauma 2008;25:1179-85.
147. Hausmann EHS, Berman NEJ, Wang Y-Y, Meara JB, Wood GW, Klein RM. Selective
chemokine mRNA expression following brain injury. Brain Res 1998;788:49-59.
148. Whalen MJ, Carlos TM, Kochanek PM, Wisniewski SR, Bell MJ, Carcillo JA, et al.
Soluble adhesion molecules in CSF are increased in children with severe head injury.
J Neurotrauma 1998;15:777-87.
149. Sandhir R, Puri V, Klein RM, Berman NEJ. Differential expression of cytokines and
chemokines during secondary neuron death following brain injury in old and young
mice. Neurosci Letters 2004;369:28-32.
150. Kushi H, Saito T, Makino K, Hayashi N. IL-8 is a key mediator of neuroinflammation in
severe traumatic brain injuries. Acta Neurochir Suppl 2003;86:347-50.
151. Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, Toshiyuki F, et al. Changes in
CSF S100 and cytokine concentrations in early-phase severe traumatic brain injury.
Shock 2004;22:102-7.
152. Gopcevic A, Mazul-Sunko B, Marout J, Sekulic A, Antoljak N, Siranovic M, et al.
Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe
traumatic brain injury. Tohoku J Exp Med 2007;211:387-93.
153. Stefini R, Catenacci E, Piva S, Sozzani S, Valerio A, Bergomi R, et al. Chemokine detec-
tion in the cerebral tissue of patients with posttraumatic brain contusions. J Neurosurg
2008;108:958-62.
154. Berman JW, Guida MP, Warren J, Amat J, Brosnan CF. Localization of monocyte
chemoattractant peptide-1 expression in the central nervous system in experimental auto-
immune encephalomyelitis and trauma in the rat. J Immunol 1996;156:3017-23.
155. Muessel MJ, Berman NEJ, Klein RM. Early and specific expression of monocyte
chemoattractant protein-1 in the thalamus induced by cortical injury. Brain Res 2000;
870:211-21.
156. Lloyd E, Somera-Molina K, Van Eldik LJ, Watterson DM, Wainwright MS. Suppression
of acute proinflammatory cytokine and chemokine upregulation by post-injury admin-
istration of a novel small molecule improves long-term neurologic outcome in a mouse
model of traumatic brain injury. J Neuroinflammation 2008;5:28-42.
